MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$770K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Other assets
Amortization of right of use ass...
Others
Negative Cash Flow Breakdown
Accrued expenses and other curre...
Lease liabilities
Net cash used in operating activ...
Other non-current liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
income (loss) from continuing operations before income taxes
-
103
-
-
Net loss from continuing operations
164
103
-612
50
Depreciation and amortization
95
94
97
287
Write-off and impairment of patents
-
-
57
31
Write-off of patents
13
-
-
-
Share-based compensation costs
4
2
51
0
Other
-
-
-
217
Other assets
-
-
-619
-529
Amortization of right of use assets
234
231
809
-
Prepaid and other current assets
-95
196
-389
-4
Other assets
-386
-881
-
-
Accounts payable
423
-340
114
-87
Accrued expenses and other current liabilities
-363
434
-237
425
Lease liabilities
-271
-266
-326
-307
Other non-current liabilities
-1
1
1
41
Total adjustments
615
841
987
949
Net cash provided by continuing operating activities
779
944
375
999
Net cash used in operating activities
-9
-8
-7
47
Net cash used in discontinued operations
-17
-
-
-
Net increase in cash and cash equivalents
770
936
368
1,046
Cash and cash equivalents - continuing operations, beginning of period
8,419
7,483
7,115
5,059
Total cash and cash equivalents, end of period
9,189
8,419
7,483
7,115
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts payable
$423K
(359.78%↑ Y/Y)
Other assets
-$386K
(55.73%↑ Y/Y)
Amortization of right of use
assets
$234K
Prepaid and other
current assets
-$95K
(-149.48%↓ Y/Y)
Depreciation and
amortization
$95K
(-50.26%↓ Y/Y)
Write-off of patents
$13K
Share-based compensation
costs
$4K
(-83.33%↓ Y/Y)
Total adjustments
$615K
(-47.48%↓ Y/Y)
Net loss from
continuing operations
$164K
(280.22%↑ Y/Y)
Canceled cashflow
$635K
Net cash provided by
continuing operating...
$779K
(-27.87%↓ Y/Y)
Accrued expenses and
other current...
-$363K
(-532.14%↓ Y/Y)
Lease liabilities
-$271K
(39.10%↑ Y/Y)
Other non-current
liabilities
-$1K
(-101.15%↓ Y/Y)
Net increase in cash
and cash...
$770K
(-23.76%↓ Y/Y)
Canceled cashflow
$17K
Net cash used in
discontinued operations
-$17K
Net cash used in
operating activities
-$9K
(87.14%↑ Y/Y)
something is missing
-$8K
Buy us a coffee
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)